MedPath

Clinical trial to evaluate the effect of photobiomodulation on cognitive and psychological tests in patients with Alzheimer's disease

Not Applicable
Recruiting
Conditions
Alzheimer.
Alzheimer disease is a primary degenerative cerebral disease of unknown etiology with characteristic neuropathological and neurochemical features. The disorder is usually insidious in onset and develops slowly but steadily over a period of several years.
Registration Number
IRCT20111121008146N35
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
12
Inclusion Criteria

Diagnosis of Alzheimer's disease by a neurologist

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DADS Test. Timepoint: At the beginning and after the end of the laser course. Method of measurement: questionnaire.;MOCA Test. Timepoint: At the beginning and after the end of the laser course. Method of measurement: questionnaire.;Hamilton Test. Timepoint: At the beginning and after the end of the laser course. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath